植入后二尖瓣反流对耐久性左心室辅助装置结局的影响
基于STS Intermacs国家数据库2017至2021年2858例全磁悬浮离心流LVAD患者,评估植入后显著二尖瓣反流对长期结局的影响。显著PI-MR定义为1或3个月随访超声中中度至重度MR,共340例。显著PI-MR与更差2年生存、再入院及后续肾衰竭风险相关。
要点
- LVAD植入后1或3个月超声提示中度至重度MR者2年生存更差(88.3% vs 79.5%,P=.008)。
- 显著PI-MR与再入院风险(HR 1.19,P=.032)及后续肾衰竭风险(HR 1.84,P=.014)升高相关。
- 术前显著MR者中17%(n=274)出现显著PI-MR,预防或干预策略待进一步研究。
核心结论
- 当代LVAD植入后显著PI-MR对长期生存和再入院产生不利影响。
研究设计与样本
- 回顾性队列研究,查询STS Intermacs国家数据库,纳入2017至2021年植入全磁悬浮离心流LVAD且符合入选与排除标准的2858例患者。
- 采用Kaplan-Meier法和Cox比例风险模型,在植入后存活3个月条件下评估PI-MR对长期结局的影响。
- 显著PI-MR定义为1或3个月随访超声心动图显示中度至重度MR。
主要发现
- 340例存在显著PI-MR,2518例无PI-MR。
- 显著PI-MR组更年轻(53.2 vs 57.7岁;P<.001),非缺血性心肌病病因比例更高(66.5% vs 51.5%;P<.0001),术前中度至重度三尖瓣反流更多(51.5% vs 37.6%;P<.001),合并三尖瓣置换/修复更多(17.1% vs 9.4%;P<.001)。
- 术前显著MR者中17%(n=274)出现显著PI-MR。
- 显著PI-MR与更差2年生存(88.3% vs 79.5%;P=.008)、再入院风险(HR 1.19;P=.032)及后续肾衰竭(HR 1.84;P=.014)相关。
临床怎么用
- LVAD患者术后1和3个月超声应关注二尖瓣反流程度,显著PI-MR提示长期生存与再入院风险更高,需加强随访与风险管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The association of significant postimplant mitral regurgitation (PI-MR) with left ventricular assist device (LVAD) outcomes remains controversial. We investigated PI-MR in the setting of contemporary LVAD therapy. METHODS: The Society of Thoracic Surgeons Intermacs National Database was queried and identified 2858 patients with a fully magnetically levitated centrifugal flow LVAD implanted from 2017 to 2021 who met study inclusion and exclusion criteria. Kaplan-Meir methodology and Cox proportional hazard modeling were used to evaluate the long-term influence of PI-MR on post-LVAD outcomes conditional on surviving 3 months post-LVAD implant. Significant PI-MR was defined as moderate-to-severe MR at the 1- or 3-month follow-up echocardiogram. RESULTS: There were 340 patients with significant PI-MR and 2518 without PI-MR following LVAD implant. Those with significant PI-MR were younger (age 53.2 vs 57.7 years; P < .001), more likely to have a nonischemic cardiomyopathy etiology of heart failure (66.5% vs 51.5%; P < .0001), preoperative moderate-to-severe tricuspid regurgitation (51.5% vs 37.6%; P < .001), and concomitant tricuspid valve replacement/repair (17.1% vs 9.4%; < .001). Of those with preoperative significant MR, 17% (n = 274) had significant PI-MR. Significant PI-MR was associated with worse 2-year survival (88.3% vs 79.5%; P = .008), risk for readmission (hazard ratio, 1.19; P = .032) and subsequent renal failure (hazard ratio, 1.84; P = .014). CONCLUSIONS: Significant PI-MR following contemporary LVAD implant adversely influences long-term survival and readmission. Strategies to prevent or intervene upon significant PI-MR require further investigation.
引用
- Pegues J, Danesh S, Cascino TM, et al. Influence of postimplant mitral regurgitation on durable left ventricular assist device outcomes. J Thorac Cardiovasc Surg. 2025. PMID: 40571187. doi:10.1016/j.jtcvs.2025.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。